ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0909
0,03%
Bitcoin
61.216,89
0,05%
Brent Oil
83,99
0,51%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Notícias

GSK

Gsk (GSK)

Gsk Plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:LSE:GSK
DataHoraFonteTítuloCódigoCompanhia
08/05/202414:21RNS Regulatory NewsGSK PLC Result of AGMLSE:GSKGsk Plc
08/05/202412:57RNS Regulatory NewsGSK PLC Board Committee ChangeLSE:GSKGsk Plc
03/05/202411:30RNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
01/05/202411:00RNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
01/05/202404:50Alliance NewsAlliance NewsTOP NEWS: GSK expects momentum to continue after strong first quarterLSE:GSKGsk Plc
01/05/202403:00RNS Regulatory NewsGSK PLC 1st Quarter ResultsLSE:GSKGsk Plc
24/04/202405:14Alliance NewsAlliance NewsGSK's Jemperli with chemotherapy accepted for priority review by FDALSE:GSKGsk Plc
24/04/202403:00RNS Regulatory NewsGSK PLC US FDA accepts new indication filing for JemperliLSE:GSKGsk Plc
17/04/202404:46Alliance NewsAlliance NewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatmentLSE:GSKGsk Plc
17/04/202403:05RNS Regulatory NewsGSK PLC GSK announces additional EAGLE-1 resultsLSE:GSKGsk Plc
17/04/202403:00RNS Regulatory NewsGSK PLC Results from long-term data relating to ShingrixLSE:GSKGsk Plc
16/04/202410:11RNS Regulatory NewsGSK PLC Amendment - Director/PDMR ShareholdingLSE:GSKGsk Plc
16/04/202404:59Alliance NewsAlliance NewsGSK's latest meningitis vaccine accepted for review by US regulatorLSE:GSKGsk Plc
16/04/202403:00RNS Regulatory NewsGSK PLC FDA accepts GSK meningitis vaccine candidate fileLSE:GSKGsk Plc
08/04/202406:27Alliance NewsAlliance NewsIN THE KNOW: Barclays ups GSK price target but HIV drug nerves remainLSE:GSKGsk Plc
04/04/202408:05RNS Regulatory NewsGSK PLC Replacement - Total Voting RightsLSE:GSKGsk Plc
25/03/202410:00RNS Regulatory NewsGSK PLC Notice of AGMLSE:GSKGsk Plc
22/03/202413:20RNS Regulatory NewsGSK PLC Transfer of Treasury SharesLSE:GSKGsk Plc
18/03/202406:30RNS Regulatory NewsGSK PLC New Phase III Jemperli data in endometrial cancerLSE:GSKGsk Plc
18/03/202405:47Alliance NewsAlliance NewsGSK says Jemperli combination gets good results for endometrial cancerLSE:GSKGsk Plc
07/03/202406:38Alliance NewsAlliance NewsGSK observes positive data in Blenrep trial for blood cancer treatmentLSE:GSKGsk Plc
07/03/202404:00RNS Regulatory NewsGSK PLC GSK announces positive Blenrep DREAMM-8 resultsLSE:GSKGsk Plc
06/03/202413:00RNS Regulatory NewsGSK PLC ViiV LAI vs oral SOC data in adherence-challengedLSE:GSKGsk Plc
05/03/202414:24RNS Regulatory NewsGSK PLC GSK Annual Report 2023 on Form 20-FLSE:GSKGsk Plc
05/03/202408:03Alliance NewsAlliance NewsGSK says ViiV's cabotegravir study supports longer HIV dose intervalLSE:GSKGsk Plc
05/03/202404:00RNS Regulatory NewsGSK PLC New ViiV LA formulation potential 4-month dosingLSE:GSKGsk Plc
01/03/202409:15RNS Regulatory NewsGSK PLC GSK publishes Annual Report 2023LSE:GSKGsk Plc
29/02/202406:44Alliance NewsAlliance NewsTOP NEWS: GSK avoids "protracted litigation" with Zantac settlementLSE:GSKGsk Plc
29/02/202404:05RNS Regulatory NewsGSK PLC Directorate ChangeLSE:GSKGsk Plc
29/02/202404:00RNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
 Apresentando as notícias mais relevantes sobre:LSE:GSK

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
VVEO3
CM Hospitalar ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
JHSF3
JHSF PART ON
BOV
BRKM5
BRASKEM PNA
BOV
PRIO3
PETRORIO ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
SGPS3
SPRINGS ON
BOV
ENAT3
ENAUTA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados